Beyond 2020 - research innovations for a new agenda

31st January 2019
John Snow Lecture Theatre, Keppel Street, London School of Hygiene & Tropical Medicine

Highlighting cutting edge NTDs research

Commemorate the 7th anniversary of the London Declaration on NTDs by joining the LCNTDR for an evening of presentations and discussion. 

This networking event will shine a spotlight on the pivotal role that NTD research plays in shaping new approaches and frameworks to controlling and eliminating NTDs. Quickfire presentations will highlight some of the new innovations and approaches that will be shaping future public health approaches. 

Keynote by Dr Mwelecele Ntuli Malecela, the new WHO Director of Control of NTDs. 

A drinks reception will be held directly following the presentations.

Research Presentations:

Advancing diagnostics: Point-Of-Need molecular diagnostics for urogenital schistosomiasis
Dr Bonnie Webster, Natural History Museum

Using sensorial anthropology to understand syndromic diagnosis in sleeping sickness
Dr Jennifer Palmer, LSHTM

Finger prints, tablets, and WaSH – can transmission of STH and Schistosomiasis be interrupted in Ethiopia?
Ms Alison Ower, Imperial College London

DeWorm3: A progress update
Dr Katherine Halliday, LSHTM

Impact, equity and cost of school-based and community-wide treatment strategies for soil-transmitted helminths in Kenya: the TUMIKIA study
Dr Rachel Pullan, LSHTM

Interrogating VL programme implementation in six countries: challenges and outcomes
Dr Lydia Boudarène, LSHTM

The importance of a One Health perspective for control of schistosomiasis in sub Saharan Africa
Dr Elsa Leger, Royal Veterinary College

Building a data platform for Chagas disease modelling
Dr Julia Halder, Imperial College London

The importance of heterogeneity in exposure to vectors of onchocerciasis
Dr Jonathan Hamley, Imperial College London

Breaking transmission for Schistosoma mansoni: Will elimination or resurgence occur after stopping treatment?
Dr Jaspreet Toor, Imperial College London

Genomic impact of mass drug administration on human infective Schistosoma mansoni
Mr Duncan Berger, Wellcome Sanger Institute

Development of CRISPR-Cas9 mediated gene drives affecting host seeking behaviour and induced refractoriness to Leishmania and Trypanosoma cruzi parasites in Sand flies and Triatomine bugs
Dr Matthew Yeo, LSHTM

Book your tickets here